Videos

Podcasts

Articles

Lymphoma

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Utilizing Services of an Integrative Medical Clinic

Using Rituximab in Non-Hodgkin Lymphoma

Tips for Championing Chemo for Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma: Mentally Preparing for Chemo

Accurately Diagnosing Non-Hodgkin Lymphoma

Understanding the Complexity of Non-Hodgkin Lymphoma

The Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee voted 16-0 in support of the agency granting approval to CT-P10, a biosimilar of Rituxan (rituximab), which is a drug used to treat non-Hodgkin lymphoma.
 

Committee Supports FDA Approval of CT-P10 for Non-Hodgkin Lymphoma Treatment

The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma. 

FDA Approves Copiktra for Two Types of Blood Cancer

September is Blood Cancer Awareness month and CURE’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:

CURE New Issue Alert: Hematology Special Issue

A recent study showed that socioeconomic status may explain racial and ethnic disparities found among childhood cancer survivors of certain cancers.
 

Socioeconomic Status May Affect Racial/Ethnic Disparities Among Childhood Cancer Survivors

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

Non-Hodgkin Lymphoma | Tumor